| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/23/2013 | CN102892897A Compositions and methods for microrna expression profiling of lung cancer |
| 01/23/2013 | CN102892787A Radioactive metal-labeled anti-cadherin antibody |
| 01/23/2013 | CN102892784A Methods for treating breast cancer |
| 01/23/2013 | CN102892779A Neuregulin antagonists and use thereof in treating cancer |
| 01/23/2013 | CN102892777A Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 01/23/2013 | CN102892770A Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/23/2013 | CN102892768A Substituted pyrrolo-aminopyrimidine compounds |
| 01/23/2013 | CN102892766A Kinase inhibitors and method of treating cancer with same |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102892755A Therapeutic compounds |
| 01/23/2013 | CN102892748A Compositions and methods for treating hyperproliferative disorders |
| 01/23/2013 | CN102892417A Compounds for immunoproteasome inhibition |
| 01/23/2013 | CN102892412A Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/23/2013 | CN102888404A Sirna conjugate and preparation method thereof |
| 01/23/2013 | CN102888279A Extracting method of corn stigma essential oil |
| 01/23/2013 | CN102887924A Preparation of active components for tyrosinase inhibition from agricultural and forestry waste walnut shell and application of active components |
| 01/23/2013 | CN102887906A Sonneratia paracaseolaris lactone oridonin, preparation method and application thereof and medicinal composition containing sonneratia paracaseolaris lactone oridonin |
| 01/23/2013 | CN102887905A Cis heterocyclic 1,2,3,4-tetrahydroisoquinoline derivatives and application thereof |
| 01/23/2013 | CN102887904A 2,3-dioxyethyl-5-methyl-8,9-dimethoxy benzophenanthridine derivative, and preparation method and application thereof |
| 01/23/2013 | CN102887900A Inhibitors of bruton's tyrosine kinase |
| 01/23/2013 | CN102887895A Pyridopyrimidine mammalian target of rapamycin (mTOR) inhibitor |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN102887869A Application of 3-acylamino-1,2,4-phentriazines to preparation of tumor sensitizer |
| 01/23/2013 | CN102887867A Triazine compound and preparation method and application of triazine compound |
| 01/23/2013 | CN102886052A Long lasting drug formulations |
| 01/23/2013 | CN102886047A Baicalein combination and preparation method thereof |
| 01/23/2013 | CN102886046A Preparation method of fat-soluble chemotherapeutic medicament loaded on calcium phosphate nano carrier and application of fat-soluble chemotherapeutic medicament in preparation of antitumor medicaments |
| 01/23/2013 | CN102886045A Method for treating gefitinib resistant cancer |
| 01/23/2013 | CN102886014A Anticancer drug capable of clearing blood and diminishing inflammation |
| 01/23/2013 | CN102886004A Traditional Chinese medicine for treating hysteromyoma |
| 01/23/2013 | CN102885988A Traditional Chinese medicine (TCM) for treating pancreatic cancers |
| 01/23/2013 | CN102885959A Method for preparing garlicin and application of garlicin |
| 01/23/2013 | CN102885949A Application of Chinese patent drug to preparation of medicament for restraining BGC-823 cell proliferation |
| 01/23/2013 | CN102885867A Extraction of anticancer substances in potherb |
| 01/23/2013 | CN102885864A Application of Chinese asafoetida seed extract to preparation of antitumor medicament |
| 01/23/2013 | CN102885854A Taiwanese green propolis extractants used for the purpose of slowing down progression of disease of patient |
| 01/23/2013 | CN102885844A Application of Houttuynoid B in medicine for treating tongue cancer |
| 01/23/2013 | CN102885843A Application of Houttuynoid B in medicament for treating breast cancer |
| 01/23/2013 | CN102885814A Compound and use of compound as anti-cancer medicine |
| 01/23/2013 | CN102885813A Pharmaceutical compositions for the treatment of hyper-proliferative disorders |
| 01/23/2013 | CN102885809A Application of Aphanamixoid A in medicament for treating pancreatic cancer |
| 01/23/2013 | CN102885806A Application of Aphanamixoid A to preparation of drug for treating laryngeal cancers |
| 01/23/2013 | CN102885786A Mixed micelle freeze-dried preparation loaded with docetaxel and preparation method thereof |
| 01/23/2013 | CN102885781A Solid dispersion of arctigenin and oral solid preparation |
| 01/23/2013 | CN102885780A Method for improving bioavailability of resveratrol |
| 01/23/2013 | CN102885778A Active carbon paclitaxel nano-drug delivery system, and preparation method and application thereof |
| 01/23/2013 | CN102885772A Docetaxel-loading mixed micelle preparation and preparation method thereof |
| 01/23/2013 | CN102885765A Irinotecan hydrochloride injection and preparation method thereof |
| 01/23/2013 | CN102335190B Reductively degradable mercaptopurine nanometer micellar prodrug with controllable drug release and application thereof |
| 01/23/2013 | CN102274181B Docetaxel lipid microsphere injection and preparation method thereof |
| 01/23/2013 | CN102268414B Coprinus comatus laccase with activity of inhibiting tumor cell proliferation and preparation method thereof |
| 01/23/2013 | CN102240343B Environment-friendly preparation method for high-ester catechin tea polyphenol |
| 01/23/2013 | CN102229939B Optimized high-activity human lysozyme gene as well as expression vectors and applications thereof |
| 01/23/2013 | CN102228483B Freeze-dried preparation of xanthone anti-tumour medicine and preparation method thereof |
| 01/23/2013 | CN102226186B Activated Bax gene for treating malignant tumor by taking adenovirus as carrier |
| 01/23/2013 | CN102225198B Anti-tumour medicine composition and preparation method and application thereof |
| 01/23/2013 | CN102210710B Bufo bufo gargarizans cantor skin extract gelskeleton sustained-release tablets and preparation method thereof |
| 01/23/2013 | CN102181407B Recombinant adenovirus and dendritic cell modified by recombinant adenovirus and application of recombinant adenovirus and dendritic cell |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN102010396B Cytospolides with anti-tumor and antibacterial activity |
| 01/23/2013 | CN102002105B Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 01/23/2013 | CN101967192B Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 01/23/2013 | CN101921329B Alpha interferon mutant and polyethylene glycol derivative thereof |
| 01/23/2013 | CN101914117B Dichloroacetoxyl-containing platinum (II) anticancer coordination compound |
| 01/23/2013 | CN101759720B Acyclic nucleoside phosphonate compounds or pharmaceutically acceptable salts thereof, preparation method, application, intermediate compounds thereof, and medicinal composition containing same |
| 01/23/2013 | CN101698089B Traditional Chinese medicine volatile oil inclusion complex and preparation method thereof |
| 01/23/2013 | CN101698031B Method for separating short-tube lycoris total alkaloids by ion exchange resin |
| 01/23/2013 | CN101687049B Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 01/23/2013 | CN101654456B Water-soluble derivants containing 10-hydroxycamptothecine and preparation method thereof |
| 01/23/2013 | CN101528263B Conjugates for innate immunotherapy of cancer |
| 01/23/2013 | CN101501035B Pyrimidine derivative as P13K inhibitor and use thereof |
| 01/23/2013 | CN101422615B Oridonin polymer micelle administration preparation and preparation method thereof |
| 01/23/2013 | CN101377487B Application of human transcription co-active factor PC4 in preparations for preparing, diagnosing, curing or preventing tumor |
| 01/23/2013 | CN101248072B 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/23/2013 | CN101128456B Quinazoline derivatives as tyrosine kinase inhibitors |
| 01/22/2013 | US8357673 4-arylazo-3,5-diamino-pyrazole compounds and use thereof |
| 01/22/2013 | US8357670 Oligomeric compounds for the modulation of HIF-1A expression |
| 01/22/2013 | US8357370 Anti-D monoclonal antibodies |
| 01/22/2013 | CA2756104C Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action |
| 01/22/2013 | CA2683946C Triazole derivatives which are smo antagonists |
| 01/22/2013 | CA2670773C 6-alkoxyalkyl estradiol derivatives and methods of use |
| 01/22/2013 | CA2560241C Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 01/22/2013 | CA2489515C Methods and compositions for modulating and detecting wisp activity |
| 01/22/2013 | CA2483819C Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 01/22/2013 | CA2448607C Colloidal metal compositions and methods |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2441663C Viral vectors and their use in therapeutic methods |
| 01/22/2013 | CA2425862C Cd19-specific redirected immune cells |
| 01/22/2013 | CA2416307C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 01/22/2013 | CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/17/2013 | WO2013010140A2 Methods of diagnosing cancer |
| 01/17/2013 | WO2013010102A2 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | WO2013010092A1 4-oxo-3,5,7,8-tetrahydro-4h-pyrano {4,3-d} pyrminidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013010018A2 Compositions and methods for inhibiting proteases |
| 01/17/2013 | WO2013009910A2 Eosinophil peroxidase compositions and methods of their use |
| 01/17/2013 | WO2013009790A2 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 01/17/2013 | WO2013009701A2 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |